🚀 VC round data is live in beta, check it out!
- Public Comps
- Bluelinea
Bluelinea Valuation Multiples
Discover revenue and EBITDA valuation multiples for Bluelinea and similar public comparables like Nestmedic, Sds Optic, Scandinavian ChemoTech, AMA Corp and more.
Bluelinea Overview
About Bluelinea
Bluelinea SA is engaged in designing and developing of electronic surveillance and medical teleassistance systems.
Founded
2014
HQ

Employees
45
Website
Sectors
Financials (FY)
EV
$15M
Bluelinea Financials
Bluelinea reported last fiscal year revenue of $12M and EBITDA of $807K.
In the same fiscal year, Bluelinea generated $8M in gross profit, $807K in EBITDA, and had net loss of ($1M).
Bluelinea P&L
In the most recent fiscal year, Bluelinea reported revenue of $12M and EBITDA of $807K.
Bluelinea expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $12M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $8M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 72% | XXX | XXX | XXX |
| EBITDA | — | XXX | $807K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (12%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (13%) | XXX | XXX | XXX |
| Net Debt | — | — | $4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Bluelinea Stock Performance
Bluelinea has current market cap of $9M, and enterprise value of $15M.
Market Cap Evolution
Bluelinea's stock price is $0.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15M | $9M | -3.6% | XXX | XXX | XXX | $-0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBluelinea Valuation Multiples
Bluelinea trades at 1.3x EV/Revenue multiple, and 18.5x EV/EBITDA.
Bluelinea Financial Valuation Multiples
As of April 20, 2026, Bluelinea has market cap of $9M and EV of $15M.
Equity research analysts estimate Bluelinea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Bluelinea has a P/E ratio of (6.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV (current) | $15M | XXX | $15M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 18.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (10.7x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.8x | XXX | XXX | XXX |
| P/E | — | XXX | (6.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (11.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Bluelinea Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Bluelinea Margins & Growth Rates
Bluelinea's revenue in the last fiscal year declined by (1%).
Bluelinea's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Bluelinea Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 3569% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 84% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Bluelinea Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Bluelinea | XXX | XXX | XXX | XXX | XXX | XXX |
| Nestmedic | XXX | XXX | XXX | XXX | XXX | XXX |
| Sds Optic | XXX | XXX | XXX | XXX | XXX | XXX |
| Scandinavian ChemoTech | XXX | XXX | XXX | XXX | XXX | XXX |
| AMA Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Zynex | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bluelinea M&A Activity
Bluelinea acquired XXX companies to date.
Last acquisition by Bluelinea was on XXXXXXXX, XXXXX. Bluelinea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Bluelinea
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBluelinea Investment Activity
Bluelinea invested in XXX companies to date.
Bluelinea made its latest investment on XXXXXXXX, XXXXX. Bluelinea invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Bluelinea
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Bluelinea
| When was Bluelinea founded? | Bluelinea was founded in 2014. |
| Where is Bluelinea headquartered? | Bluelinea is headquartered in France. |
| How many employees does Bluelinea have? | As of today, Bluelinea has over 45 employees. |
| Is Bluelinea publicly listed? | Yes, Bluelinea is a public company listed on Euronext Paris. |
| What is the stock symbol of Bluelinea? | Bluelinea trades under ALBLU ticker. |
| When did Bluelinea go public? | Bluelinea went public in 2012. |
| Who are competitors of Bluelinea? | Bluelinea main competitors are Nestmedic, Sds Optic, Scandinavian ChemoTech, AMA Corp. |
| What is the current market cap of Bluelinea? | Bluelinea's current market cap is $9M. |
| What is the current revenue of Bluelinea? | Bluelinea's last fiscal year revenue is $12M. |
| What is the current EV/Revenue multiple of Bluelinea? | Current revenue multiple of Bluelinea is 1.3x. |
| Is Bluelinea profitable? | No, Bluelinea is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.